103 related articles for article (PubMed ID: 1831676)
1. Is the erythrocyte sodium-lithium countertransport a molecular marker of cardiac risk in hypertension?
Diez J; Arrazola A
Cardioscience; 1991 Jun; 2(2):87-92. PubMed ID: 1831676
[TBL] [Abstract][Full Text] [Related]
2. [Erythrocyte sodium-lithium countertransport in diabetic children: 12 months development and relationship with familial hypertension].
Guarena C; Boero R; Quarello F; Cerruti F; Rolando B; Sacchetti C; Rosati C; Iadarola G; Piccoli G
Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1205-7. PubMed ID: 1482260
[TBL] [Abstract][Full Text] [Related]
3. G-protein beta3-subunit gene variant, blood pressure and erythrocyte sodium/lithium countertransport in essential hypertension.
Poch E; González-Núñez D; Compte M; De la Sierra A
Br J Biomed Sci; 2002; 59(2):101-4. PubMed ID: 12113397
[TBL] [Abstract][Full Text] [Related]
4. Abnormal kinetics of erythrocyte sodium lithium countertransport in patients with diabetic nephropathy in Thailand.
Vareesangthip K; Panthongdee W; Shayakul C; Nitiyanant W; Ong-Aj-Yooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S48-53. PubMed ID: 17044454
[TBL] [Abstract][Full Text] [Related]
5. Nonlinear relationship between erythrocyte sodium-lithium countertransport and blood pressure in man.
Petrov VV; Britov AN; Levitsky DO; Minchenko BI; Konstantinov EN; Svidersky VD; Novikov ID; Grishenkov EA; Lijnen PJ
Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):661-6. PubMed ID: 7746028
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for left ventricular hypertrophy: role of Na(+)-Li+ countertransport.
Neves PL; Faisca M; Gomes V; Cacodcar S; Bernardo I; Anunciada AI; Viegas E; Martins H; da Silva AM
Kidney Int Suppl; 1996 Jun; 55():S160-2. PubMed ID: 8743543
[TBL] [Abstract][Full Text] [Related]
7. Genetic differences in lithium-sodium exchange and regulation of the sodium-hydrogen exchanger in essential hypertension.
Canessa ML; Morgan K; Semplicini A
J Cardiovasc Pharmacol; 1988; 12 Suppl 3():S92-8. PubMed ID: 2467112
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte Na+/Li+ countertransport and Na+/K+ -2Cl- co-transport in essential hypertension.
Hardman T; Clifford RH; Wierzbicki AS
Clin Sci (Lond); 1999 Sep; 97(3):339-41. PubMed ID: 10576963
[No Abstract] [Full Text] [Related]
9. Red blood cell sodium-lithium countertransport in patients with essential and renal hypertension.
Petrov VV; Arabidze CG; Levitsky DO; Eliseev AO; Lijnen PJ
Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):153-7. PubMed ID: 8007744
[TBL] [Abstract][Full Text] [Related]
10. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
[TBL] [Abstract][Full Text] [Related]
11. [Red-cell sodium-lithium countertransport in patients with IgA nephrology and renal hypertension].
Chen YD; Zheng FL; Wen LR
Zhonghua Yi Xue Za Zhi; 1994 Apr; 74(4):214-7, 254. PubMed ID: 7922761
[TBL] [Abstract][Full Text] [Related]
12. [Erythrocyte sodium-lithium countertransport in diabetic adolescents].
Guarena C; Boero R; Quarello F; Rolando B; Sacchetti C; Dianzani I; Maffei S; Cerutti F; Piccoli G
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1249-51. PubMed ID: 2124463
[TBL] [Abstract][Full Text] [Related]
13. Sodium/lithium countertransport and intracellular calcium concentration in patients with essential hypertension and coronary heart disease.
Gruska S; Jendral I; Rettig R; Kraatz G
Clin Sci (Lond); 2003 Mar; 104(3):323-7. PubMed ID: 12605593
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and not hyperinsulinaemia determines erythrocyte Na+/Li+ countertransport in non-insulin-dependent diabetes mellitus.
Pinkney JH; Denver AE; Foyle WJ; Foster C; Yudkin JS
J Hum Hypertens; 1995 Aug; 9(8):685-6. PubMed ID: 8523391
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell Li+-Na+ countertransport, Na+-K+ cotransport, and the hemodynamics of hypertension.
Weder AB; Fitzpatrick MA; Torretti BA; Hinderliter AL; Egan BM; Julius S
Hypertension; 1987 May; 9(5):459-66. PubMed ID: 3570422
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes.
Vaccaro O; Cuomo V; Trevisan M; Cirillo M; Panarelli W; Laurenzi M; Mancini M; Riccardi G;
Int J Epidemiol; 2005 Oct; 34(5):1123-8. PubMed ID: 16087689
[TBL] [Abstract][Full Text] [Related]
17. Altered membrane microviscosity in essential hypertension: relationship with family history of hypertension and sodium-lithium countertransport activity.
Carr SJ; Sikand K; Moore D; Norman RI
J Hypertens; 1995 Jan; 13(1):139-46. PubMed ID: 7759844
[TBL] [Abstract][Full Text] [Related]
18. [Hypertension: when to consider it a risk factor?].
Pessina AC; Rossi GP
Recenti Prog Med; 1992 Sep; 83(9):515-9. PubMed ID: 1439121
[TBL] [Abstract][Full Text] [Related]
19. Relevance of erythrocyte Na+/Li+ countertransport measurement in essential hypertension, hyperlipidaemia and diabetic nephropathy: a critical review.
Van Norren K; Thien T; Berden JH; Elving LD; De Pont JJ
Eur J Clin Invest; 1998 May; 28(5):339-52. PubMed ID: 9650006
[TBL] [Abstract][Full Text] [Related]
20. Evidence for an altered mode of action of the sodium-lithium countertransporter in vivo in patients with untreated essential hypertension.
Brearley CJ; Wood AJ; Aronson JK; Grahame-Smith DG
J Hypertens; 1993 Feb; 11(2):147-53. PubMed ID: 8385174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
